⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21875167 | 0.67 | — | — | |
| SCHEMBL4360702 | 0.61 | — | — | |
| Ethyne SCHEMBL15388351 | 0.58 | — | — | |
| SCHEMBL407604 | 0.54 | — | — | |
| SCHEMBL25299 | 0.50 | — | — | |
| SCHEMBL231401 | 0.50 | — | — | |
| SCHEMBL9068679 | 0.50 | — | — | |
| SCHEMBL9613790 | 0.50 | — | — | |
| SCHEMBL130536 | 0.50 | — | — | |
| SCHEMBL15304113 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116964122-A | Polyurea copolymers | 巴斯夫欧洲公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-109970629-B | Process for preparing antifungal compounds | 迈科维亚医药公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-114269383-A | Metalloenzyme inhibitor compounds | 菲斯生物制药公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-108347949-B | Antifungal compound method | NQP 1598公司 | 2021-08-13 | — | — | CN | disclosed |
| CN-108289457-B | Process for preparing antifungal compounds | 迈科维亚医药公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-107428724-B | Antifungal compound and preparation method thereof | 迈科维亚医药公司 | 2021-07-02 | — | — | CN | disclosed |
| US-20200165520-A1 | MATRIX FORMULATION FOR POLYMER DISPERSED LIQUID CRYSTAL DISPLAYS IN LOW POWER DIRECT CURRENT (DC) ELECTROMAGNETIC FIELD APPLICATION | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2020-05-28 | — | — | US | disclosed |
| CN-110719781-A | Substituted piperidine MnK inhibitors and methods related thereto | 效应治疗股份有限公司 | 2020-01-21 | — | — | CN | disclosed |
| CN-109983006-A | Crystalline forms of lysyl oxidase-like 2 inhibitors and methods of making the same | 法玛克亚公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-109890833-A | The nanoparticle based on three block polypeptide for delivery of hydrophilic drug | 杜克大学 | 2019-06-14 | — | — | CN | disclosed |
| EP-2046147-B1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2013-05-01 | — | — | EP | disclosed |
| US-8344154-B2 | 2-thioethenyl substituted carbapenem derivatives | MEIJI SEIKA KAISHA, LTD. (JP) | 2013-01-01 | — | — | US | disclosed |
| CN-102448494-A | Immunoconjugates having an intracellularly cleavable linkage | IMMUNOMEDICS INC | 2012-05-09 | — | — | CN | disclosed |
| US-20100145063-A1 | 2- thioethenyl substituted carbapenem derivatives | MARUYAMA TAKAHISA | 2010-06-10 | — | — | US | disclosed |
| US-7687490-B2 | 2-thioethenyl substituted carbapenem derivatives | MEIJI SEIKA KAISHA, LTD. (JP) | 2010-03-30 | — | — | US | disclosed |
| US-20090311403-A1 | Method of Using Organic Compounds | GIVAUDAN SA (CH) | 2009-12-17 | — | — | US | disclosed |
| EP-2046147-A1 | METHOD OF USING ORGANIC COMPOUNDS | Givaudan SA (CH) | 2009-04-15 | — | — | EP | disclosed |
| CN-101193891-A | 2-thioethenyl substituted carbapenem derivatives | MEIJI SEIKA KAISHA (JP) | 2008-06-04 | — | — | CN | disclosed |
| WO-2008011742-A1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-01-31 | — | — | WO | disclosed |
| US-20070004700-A1 | 2-Thioethenyl substituted carbapenem derivatives | MEIJI SEIKA KAISHA, LTD. (JP) | 2007-01-04 | — | — | US | disclosed |